(±)-Enitociclib (Standard)

(Synonyms: (±)-BAY-1251152 (Standard); (±)-VIP152 (Standard))

(±)-Enitociclib (Standard) is the analytical standard of (±)-Enitociclib (HY-103019A). This product is intended for research and analytical applications. (±)-Enitociclib ((±)-BAY-1251152) is the racemic mixture of Enitociclib (HY-103019E). Enitociclib is a selective CDK9 inhibitor and apoptosis inducer. Enitociclib inhibits CDK9 activity and reduces the phosphorylation of Ser2 in the carboxyl-terminal domain (CTD) of RNA polymerase Pol II, thereby downregulating the transcription of key oncogenes such as MYC and MCL1. Enitociclib has anti-proliferative activity targeting MYC+ lymphoma and multiple myeloma (MM) cells, and has synergistic effects with Bortezomib (HY-10227) and Lenalidomide (HY-A0003), and can be used in the research of hematological malignancies.

For research use only. We do not sell to patients.

  • CAS No.: 1610358-53-6
  • Formula: C19H18F2N4O2S
  • Molecular Weight:404.43
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Product Information
  • Chemical Information
  • Purity & Documentation
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00